SG
BNTX icon

Sankala Group’s BioNTech BNTX Stock Holding History

Sankala Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Buy
2,694
+94
+4% +$9.66K 0.19% 109
2025
Q4 		$287K Buy
+2,600
New +$262K 0.23% 97

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sankala Group's BNTX Position: Q1 2026 in Review

Sankala Group increased its BioNTech (BNTX) stake by 3.6% in Q1 2026, buying an estimated $9.66K and bringing the position to 2,694 shares worth $234K. The position accounts for 0.19% of the portfolio, ranked #109.

Sankala Group first reported a position in BNTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $287K in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Sankala Group held 2,694 shares of BioNTech worth $234K as of Q1 2026.
  • Sankala Group bought 94 BioNTech shares in Q1 2026, an estimated $9.66K.
  • BioNTech made up 0.19% of Sankala Group's portfolio in Q1 2026, its #109 holding.
  • Sankala Group first reported a position in BioNTech in Q4 2025 and has held it in 2 quarters since.
  • Sankala Group's BioNTech position peaked at $287K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.